What the FDA’s full approval of the Pfizer-BioNTech coronavirus vaccine means. Plus, big business pledged nearly $50 billion for racial justice after George Floyd’s killing. Where did the money go?

Read more:

Goodbye, “emergency use authorization.” Hello, “full approval.” On Monday, the Food and Drug Administration gave full approval to the Pfizer-BioNTech coronavirus vaccine, commercially called Comirnaty. The four-month evaluation process was fast by the FDA’s usual standards, but regulators have emphasized that they did not sacrifice any kind of rigor in the process. Health and science writer Ben Guarino reports on the effect that full approval could have on vaccine mandates –– and whether it will change the hearts and minds of the vaccine-hesitant. 

After the murder of George Floyd ignited nationwide protests, corporate America promised to take an active role in confronting systemic racism. Now, more than a year after leading businesses pledged money toward racial-justice causes, reporter Tracy Jan analyzes where that money actually went. 

On Tuesday, the Supreme Court said the Biden administration must comply with a ruling from a lower court to restart President Donald Trump’s “Remain in Mexico” policy for asylum seekers. This was the program that forced people seeking asylum in the United States to wait on the other side of the southern border, in Mexico. It’s unclear what this new mandate will mean for the controversial program, but last month our podcast aired a two-part story about what living under this program is actually like for an asylum seeker. To better understand what it means to “remain in Mexico,” you can find those episodes — “Marooned in Matamoros,” Parts 1 and 2 — at this link.